Ressource Scientifique

Publication: The Nature of Nanodisc Lipids Influences Fragment-Based Drug Discovery Results
Discover how nanodisc lipids impact fragment-based drug discovery, enhancing membrane protein screening and enabling new therapeutic possibilities.

Cooperativity: The Missing Link in Molecular Glue Discovery
In this Q&A, discover how cooperativity is unlocking new potential in molecular glues and enabling the targeting of previously “undruggable” proteins.

Case study: Capturing out-of-range target engagement kinetics for an advanceable clinical candidate
Characterizing the inhibition of PRMT5:MTA by MRTX1719, a clinical stage MTAP-deleted cancer therapeutic.

Medicinal Chemist’s Insights into the Microbiome
Here, we highlight the need to consider early the microbiome in drug discovery, as it may influence drug responses, therefor efficacy

The Game-Changing Role of Artificial Intelligence in Drug Discovery
Discover in this blog how Artificial Intelligence (AI) has a game-changing role in drug discovery and computational chemistry

Radionuclides: a sourcing challenge
In this blog, we deal with overcoming radionuclides supply challenges with innovative solutions by Oncodesign Services

How Oncodesign Services contributed to the Development of a New COVID-19 Vaccine
Oncodesign Services provided valuable support in bioanalysis and dosage for the development on new vaccine against COVID-19.

Meeting with Patrick Jimonet (Medicen)
In this interview, discover how Patrick Jimonet led and united over thirty prominent international experts to develop proposals aimed at facilitating the integration of the microbiome into drug discovery. 💊

How to target RNA modulation with small molecule?
In this two-part free webinar series, we've assembled a team of leading experts who will delve into the intricacies of RNA modulation, explore its potential applications, and showcase real-world case studies.

Intra-cranial administration of MTL-004, a promising post-resection treatment for glioblastoma
Gliomas (GBM), are exceptionally hard to treat, aggressive and genetically heterogeneous tumors. Read the poster to discover the case study!

Evaluation of checkpoint inhibitor efficacy in a humanized immune system mouse model lacking murine Fc gamma receptors
Humanized immune system (HIS) mice are critical immuno-oncology tools for evaluating antibody-based therapeutic target engagement and efficacy in a human-like context

New technologies and capabilities supporting the development of novel Molecular RadioTherapy agents
Read our Oncodesign-Services' poster which provides cutting-edge technologies and products to support the development of radiopharmaceuticals for theranostics.